Rosenberg Noah L.
Related Filers (2)
Ownership (20)
4
Tuesday, 8/17/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/29/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/13/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/5/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/3/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/25/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/23/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/22/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/30/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/13/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/9/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/31/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/31/2019
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/10/2019
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 7/30/2018
Retrophin, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 7/30/2018
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/25/2013
Esperion Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/25/2013
Esperion Therapeutics, Inc.: Initial statement of beneficial ownership of securities